臨床意思決定支援システム（CDSS）市場：コンポーネント（サービス、ソフトウェア）、デリバリー（オンプレミス、クラウド）、製品（スタンドアロン、統合）、アプリケーション（先進、治療、診断）、インタラクティビティ（アクティブ、パッシブ）- 2027年までの世界予測

Clinical Decision Support Systems (CDSS) Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) - Global Forecasts to 2027

臨床意思決定支援システム（CDSS）の世界市場は、2022年の15億米ドルから2027年には22億米ドルに達し、予測期間中のCAGRは7.9％と予測されています。この市場の成長は、HCITソリューションの採用を促進するために... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年7月11日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	232	237	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

臨床意思決定支援システム（CDSS）の世界市場は、2022年の15億米ドルから2027年には22億米ドルに達し、予測期間中のCAGRは7.9％と予測されています。この市場の成長は、HCITソリューションの採用を促進するために実施されるさまざまな政府規制やイニシアチブ、CDSS統合EHRの採用増加、競合企業間のコラボレーションやパートナーシップの成長、投薬エラーの発生率の増加、mHealthやビッグデータツールの開発などが要因となっています。
しかし、CDSS導入のための高額な投資や、データセキュリティの懸念の高まりと相まって相互運用性の問題が、予測期間中の同市場の成長を抑制する要因になると予想されます。

"ソフトウェア分野は予測期間中に最も高い成長率を示すと予想される"
CDSS市場はコンポーネントベースで、：サービス、ソフトウェア、ハードウェアに区分されます。2021年の同市場では、サービス分野が最大のシェアを占めている。このセグメントの成長は、トレーニングや開発、インストール、コンサルティング、メンテナンスなどのサービスの経常的な性質に起因しています。

"2022年の臨床意思決定支援システム市場は、オンプレミスソリューションセグメントが最大のシェアを占めると予測される"
配信モードに基づいて、臨床意思決定支援システムは、オンプレミスおよびクラウドベースのモードを通じてエンドユーザーに提供されます。2021年の臨床意思決定支援システム市場では、オンプレミス型の配信モードが最大のシェアを占めています。一方、クラウドベースの配信モードは、拡張性、柔軟性、手頃な価格と並んで、このモデルで発生する資本費用や運用コストが低いため、最も高いCAGRで成長すると推定される。

"臨床意思決定支援システムの世界市場において、従来型CDSSセグメントが最大のシェアを占めている"
CDSS市場は、アプリケーションに基づいて、従来型CDSSと先進型CDSSに区分されます。2021年では、従来型CDSSセグメントが最大のシェアを占めています。従来型CDSSは、主にポイントオブケアで介護者にガイダンス＆リマインダーを提供するために、医療機関がCDSSの採用を増やしていることが原因で、市場で最大のシェアを占めています。

「統合型CDSSは、臨床意思決定支援システムの世界市場において最大のシェアを占めています。
CDSS市場は、製品に基づき、統合型CDSSとスタンドアロン型CDSSに区分されます。2021年では、統合型CDSSセグメントが最大のシェアを占めています。このセグメントの大きなシェアは、医療現場や組織における統合型CDSSの採用が進んでいることに起因しています。

"治療用CDSSセグメントは、予測期間中に最も高いCAGRで成長すると予想される"
臨床意思決定支援システム市場は、タイプ別に、治療用CDSSと診断用CDSSに区分されます。2021年には、治療用CDSSセグメントがこの市場を支配しました。このセグメントは、予測期間中に高いCAGRで成長すると推定されます。このセグメントの大きなシェアと高い成長率は、治療用CDSSが臨床ワークフローとの適合性が高いため、診断用CDSSよりも臨床医に好まれるといった要因によるものである。また、医療従事者の自律性を制限しないため、使い勝手が良いことも挙げられます。

"臨床意思決定支援システムの世界市場において、知識ベースCDSSセグメントが最大のシェアを占める"
CDSS市場は、モデルに基づいて、知識ベースCDSSと非知識ベースCDSSに分類されます。2021年には、ナレッジベースCDSSセグメントが最大のシェアを占めています。また、同セグメントは予測期間中に最も高いCAGRを記録すると推定される。このセグメントの大きなシェアと高い成長は、知識ベースの推論で臨床医を支援し、不確実性の中で臨床決定を行うなど、これらのシステムのいくつかの利点に起因することができます。また、これらのシステムは、臨床ワークフローに統合することができ、エラーが発生する可能性も低くなります。

"アクティブCDSS分野は予測期間中に最も高いCAGRで成長すると予想される"
インタラクティブ性のレベルに基づいて、CDSS市場はアクティブCDSSとパッシブCDSSに区分されることができます。アクティブCDSSセグメントは、2021年に市場で最大のシェアを占め、予測期間中に最も高いCAGRで成長すると予測されます。

"臨床意思決定支援システムの世界市場において、入院患者の設定が最大のシェアを占める"
設定に基づき、CDSS市場は入院患者設定と外来患者設定に区分されます。2021年のCDSS市場では、入院患者のセッティングが最大のシェアを占めています。入院患者環境では、大量の患者データを取得し、分析する必要があり、その結果、統合医療ITモジュールの導入が進んでいます。

"2022年、北米が臨床意思決定支援システム市場を支配する"
2021年の世界臨床意思決定支援システム市場は、北米が最大のシェアを占めています。北米市場の大きなシェアは、HCITソリューションへの顕著な投資、CDSSの導入に有利な規制命令、この地域における主要な市場プレイヤーの存在、米国とカナダにおける投薬ミスの増加などに起因していると考えられます。
アジア太平洋地域は、予測期間中に最も高いCAGRを記録すると予測されています。これは、大規模な高齢者人口の存在、政府規制の改善、慢性疾患の高い負担、アジアの新興国に対するさまざまな市場プレイヤーの関心の高まりといった要因が、アジアにおけるCDSS市場の成長を促進すると考えられているためです。

供給側一次インタビューの内訳、企業タイプ別、呼称別、地域別。
- 企業タイプ別ティア1 (45%)、ティア2 (35%)、ティア3 (20%)
- 役職別Cレベル(26%)、ディレクターレベル(17%)、その他(57%)
- 地域別北米 (40%)、欧州 (20%)、アジア太平洋 (30%)、RoW (10%)

CDSS市場で事業を展開している主な企業は、Cerner Corporation（米国）、Change Healthcare（米国）、Epic Systems（米国）、MEDITECH（米国）、Philips Healthcare（オランダ）、Wolters Kluwer N.V.（オランダ）、Zynx Health（米国）、Elsevier B.V. （英国）です。(英国）、IBM Watson Health（米国）、Allscripts Healthcare LLC（米国）、athenahealth（米国）、NextGen Healthcare（米国）、Siemens Healthineers（米国）、EBSCO Health（米国）、GE Healthcare（米国）、eClinicalWorks（米国）、RAMPMedical（ドイツ）です。The Medical Algorithms Company Limited（英国）、Hera-MI（フランス）、CureMD Healthcare（米国）、CareCloud, Inc（米国）、Visual DX（米国）、Stanson Health（米国）、First Databank, Inc（米国）、および Strata Decision Technology（米国）。

調査対象範囲
- このレポートは、臨床意思決定支援システム市場をコンポーネント、配信モード、製品、モデル、対話性レベル、アプリケーション、設定、タイプ、地域に基づいて調査しています。
- 市場成長に影響を与える要因（ドライバー、阻害要因、機会、課題など）を分析しています。
- 利害関係者向けに市場の機会および課題を評価し、市場リーダー向けに競争環境の詳細を提供しています。
- ミクロ市場の成長動向、展望、臨床意思決定支援システム市場全体への貢献度に関して調査しています。
- 主要5地域に関する市場セグメントの売上高を予測しています。

レポート購入の主なメリット

本レポートは、市場全体とサブセグメントに関する収益数の最も近い近似値に関する情報を提供し、この市場のリーダー/新規参入者を支援します。本レポートは、利害関係者が競争環境を理解し、より良いビジネスの位置づけと適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、ステークホルダーが臨床意思決定支援システム市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

ページTOPに戻る

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.2.1 CLINICAL DECISION SUPPORT SYSTEM MARKET: INCLUSIONS & EXCLUSIONS 24
1.3 MARKET SCOPE 25
1.3.1 MARKETS COVERED 25
FIGURE 1 CDSS MARKET SEGMENTATION 25
1.3.2 YEARS CONSIDERED FOR THE STUDY 25
1.4 CURRENCY 26
1.5 LIMITATIONS 26
1.5.1 SCOPE-RELATED LIMITATIONS 26
1.5.2 METHODOLOGY-RELATED LIMITATIONS 26
1.6 STAKEHOLDERS 26
1.7 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
FIGURE 2 RESEARCH DESIGN 28
2.1.1 SECONDARY DATA 29
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY RESEARCH 30
FIGURE 3 PRIMARY SOURCES 31
2.1.2.1 Key industry insights 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 32
2.2 MARKET SIZE ESTIMATION METHODOLOGY 33
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 33
2.3 MARKET ESTIMATION 34
FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION 34
2.3.1 APPROACH: END USER-BASED MARKET ESTIMATION 35
FIGURE 7 MARKET-SIZE ESTIMATION 35
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 36
FIGURE 8 DATA TRIANGULATION METHODOLOGY 36
2.5 ASSUMPTIONS FOR THE STUDY 37
2.6 RISK ASSESSMENT 38
TABLE 1 RISK ASSESSMENT: CLINICAL DECISION SUPPORT SYSTEMS MARKET 38
2.7 LIMITATIONS 38
3 EXECUTIVE SUMMARY 39
FIGURE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION) 39
FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 40
FIGURE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 40
FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2022 VS. 2027 (USD MILLION) 41
FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 42
FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION) 42
FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2022 VS. 2027 (USD MILLION) 43
FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2022 VS. 2027 (USD MILLION) 44
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET 45
4 PREMIUM INSIGHTS 46
4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW 46
FIGURE 18 RISING GOVERNMENT INITIATIVES FOR THE ADOPTION OF HCIT SOLUTIONS DRIVE THE MARKET GROWTH 46
4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY 47
FIGURE 19 US DOMINATED THE MARKET IN NORTH AMERICA (2021) 47
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY PRODUCT 47
FIGURE 20 INTEGRATED CDSS SEGMENT TO DOMINATE THE MARKET FROM 2022 TO 2027 47
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 21 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
5.2.1 DRIVERS 50
5.2.1.1 Implementation of government regulations & initiatives to promote the adoption of HCIT solutions 50
5.2.1.2 Increasing adoption of CDSS-enabled EHRs 51
5.2.1.3 Growing collaborations & partnerships among stakeholders 51
TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022 52
5.2.1.4 Growing incidence of medication errors 52
5.2.1.5 Development of big data and mHealth tools 53
5.2.2 RESTRAINTS 53
5.2.2.1 Data security concerns related to cloud-based CDSS 53
5.2.2.2 Inadequate interoperability 53
5.2.3 OPPORTUNITIES 54
5.2.3.1 The growth potential of emerging markets 54
5.2.3.2 Social media integration and rising technological advancements 54
5.2.4 CHALLENGES 55
5.2.4.1 Requirement of high investments for the implementation of CDSS infrastructure 55
5.2.4.2 Shortage of skilled IT professionals in the healthcare industry 55
5.3 IMPACT OF COVID-19 ON THE CLINICAL DECISION SUPPORT SYSTEMS MARKET 56
5.4 VALUE-CHAIN ANALYSIS 56
FIGURE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE-CHAIN ANALYSIS (2021) 56
5.5 CASE STUDIES 57
5.5.1 IMPROVING RESPONSE PHYSICIAN EFFICIENCY AND TIME 57
TABLE 3 CASE 1: NEED TO PROVIDE BETTER FACILITIES 57
5.5.2 IMPROVING EFFICIENCY AND CARE WITH AI 57
TABLE 4 CASE 2: IMPROVING EFFICIENCY, ADOPTION, AND CARE EXPERIENCES WITH AI-POWERED CDS 57
5.5.3 PROVIDING THE BEST PATIENT CARE 58
TABLE 5 CASE 3: FOCUS ON QUALITY AND SAFETY 58
5.6 ECOSYSTEM ANALYSIS 58
FIGURE 24 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECO SYSTEM ANALYSIS (2021) 58
5.7 TECHNOLOGY ANALYSIS 59
TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 59
5.8 REGULATORY ANALYSIS 60
5.8.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA) 60
5.8.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH) 60
5.8.3 CONSUMER PRIVACY PROTECTION ACT OF 2017 60
5.8.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015 60
5.8.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA 61
5.8.6 AFFORDABLE CARE ACT, 2010 61
5.9 PORTER'S FIVE FORCES ANALYSIS 61
TABLE 7 CDSS MARKET: PORTER’S FIVE FORCES ANALYSIS 61

5.10 INDUSTRY TRENDS 62
5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION FOR HCIT SOLUTIONS 62
5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS 62
5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE 63
5.11 PRICING ANALYSIS 64
TABLE 8 AVERAGE SELLING PRICE OF CDSS SOLUTIONS, BY PRODUCT (2021) 64
5.12 CONFERENCES AND WEBINARS 64
5.13 BUSINESS MODELS 65
FIGURE 25 BENEFITS OF HYBRID BUSINESS MODELS 65
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT 66
6.1 INTRODUCTION 67
TABLE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 67
6.2 SERVICES 67
6.2.1 SERVICES SEGMENT TO DOMINATE THE MARKET FROM 2022–2027 67
TABLE 10 CLINICAL DECISION SUPPORT SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 68
6.3 SOFTWARE 69
6.3.1 THE USE OF EMR/EHR-INTEGRATED CDSS ENABLES ACCESS TO CENTRALIZED PATIENT DATABASES 69
TABLE 11 CLINICAL DECISION SUPPORT SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 69
6.4 HARDWARE 69
6.4.1 HARDWARE MUST BE FREQUENTLY UPGRADED OR REPLACED FOR THE OPTIMAL USE OF ADVANCED SOFTWARE 69
TABLE 12 CLINICAL DECISION SUPPORT HARDWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 70
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT 71
7.1 INTRODUCTION 72
TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 72
7.2 INTEGRATED CDSS 72
7.2.1 INTEGRATED CDSS IS WIDELY USED BY HEALTHCARE PROVIDERS TO IMPROVE THE QUALITY OF CARE AND REDUCE MEDICATION ERRORS 72
TABLE 14 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 73
7.3 STANDALONE CDSS 74
7.3.1 LACK OF INTEROPERABILITY WITH CPOE AND EHR TO RESTRAIN THE MARKET DEMAND 74
TABLE 15 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 74

8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE 75
8.1 INTRODUCTION 76
TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 76
8.2 THERAPEUTIC CDSS 76
8.2.1 THERAPEUTIC CDSS IS MOST EFFECTIVE IN INTEGRATED CLINICAL WORKFLOWS AS IT REDUCES MEDICATION ERRORS 76
TABLE 17 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 77
8.3 DIAGNOSTIC CDSS 77
8.3.1 DIAGNOSTIC CDSS GUIDES PHYSICIANS THROUGH A SYSTEMATIC DIAGNOSIS PROCESS 77
TABLE 18 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 77
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL 78
9.1 INTRODUCTION 79
TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 79
9.2 KNOWLEDGE-BASED CDSS 79
9.2.1 KNOWLEDGE-BASED CDSS MODELS USE CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS 79
TABLE 20 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 80
9.3 NON-KNOWLEDGE-BASED CDSS 80
9.3.1 NON-KNOWLEDGE-BASED CDSS IMPLEMENTS ML AND AI ALGORITHMS TO EXPAND ITS USER-DEFINED KNOWLEDGE BASE 80
TABLE 21 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 81
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE 82
10.1 INTRODUCTION 83
TABLE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 83
10.2 ON-PREMISE CDSS 83
10.2.1 LICENSED SOFTWARE IS INSTALLED ON ON-PREMISE CDSS DELIVERY MODES 83
TABLE 23 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 84
10.3 CLOUD-BASED CDSS 84
10.3.1 CLOUD-BASED CDSS IS PROJECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 84
TABLE 24 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 85

11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION 86
11.1 INTRODUCTION 87
TABLE 25 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
11.2 CONVENTIONAL CDSS 87
11.2.1 CONVENTIONAL CDSS IS USED TO ENHANCE HEALTH-RELATED DECISION-MAKING 87
TABLE 26 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 88
11.3 ADVANCED CDSS 88
11.3.1 ADVANCED CDSS SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 88
TABLE 27 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 89
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL 90
12.1 INTRODUCTION 91
TABLE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 91
12.2 ACTIVE CDSS 91
12.2.1 ACTIVE CDSS IS THE LARGEST AND THE FASTEST-GROWING SEGMENT IN THE CDSS MARKET 91
TABLE 29 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 92
12.3 PASSIVE CDSS 92
12.3.1 PASSIVE CDSS CAUSES MINIMAL DISRUPTION TO WORKFLOWS 92
TABLE 30 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 93
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING 94
13.1 INTRODUCTION 95
TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 95
13.2 INPATIENT SETTINGS 95
13.2.1 THE ADOPTION OF CDSS FOR INPATIENT SETTINGS HELPS IMPROVE PATIENT CARE WORKFLOWS 95
TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY REGION, 2020–2027 (USD MILLION) 96
13.3 AMBULATORY CARE SETTINGS 96
13.3.1 THE RISING NEED TO CONTROL HEALTHCARE COSTS DRIVES THE DEMAND FOR CDSS IN AMBULATORY CARE SETTINGS 96
TABLE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION) 97

14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION 98
14.1 INTRODUCTION 99
FIGURE 26 NORTH AMERICA TO DOMINATE THE CDSS MARKET FROM 2022 TO 2027 99
TABLE 34 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
14.2 NORTH AMERICA 100
FIGURE 27 NORTH AMERICA: CDSS MARKET SNAPSHOT 100
TABLE 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 101
TABLE 37 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 101
TABLE 38 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102
TABLE 39 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 40 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 102
TABLE 41 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 103
TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103
TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 103
14.2.1 US 104
14.2.1.1 The US is the largest market for CDSS solutions 104
TABLE 44 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 105
TABLE 45 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 105
TABLE 46 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105
TABLE 47 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 106
TABLE 48 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 106
TABLE 49 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 106
TABLE 50 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107
TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 107
14.2.2 CANADA 107
14.2.2.1 The rising requirement for cost containment drives the market growth in Canada 107
TABLE 52 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 108
TABLE 53 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 108
TABLE 54 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109
TABLE 55 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 56 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 109
TABLE 57 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 110
TABLE 58 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110
TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 110
14.3 EUROPE 111
TABLE 60 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 61 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 111
TABLE 62 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 112
TABLE 63 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 112
TABLE 64 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 65 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 113
TABLE 66 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 113
TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 114
14.3.1 GERMANY 114
14.3.1.1 Government initiatives to boost the adoption of EMRs drives the market growth in Germany 114
TABLE 69 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 115
TABLE 70 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 115
TABLE 71 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 115
TABLE 72 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 73 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 116
TABLE 74 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 116
TABLE 75 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 117
TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 117
14.3.2 UK 117
14.3.2.1 Favorable government initiatives drive the demand for CDSS solutions in the UK 117
TABLE 77 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 118
TABLE 78 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 118
TABLE 79 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 80 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 81 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 119
TABLE 82 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 120
TABLE 83 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 120
TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 120
14.3.3 FRANCE 121
14.3.3.1 The rising focus on improving the healthcare system in France drives the market demand for CDSS 121
TABLE 85 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 121
TABLE 86 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 122
TABLE 87 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 88 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 89 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 123
TABLE 90 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 123
TABLE 91 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 123
TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 124
14.3.4 ITALY 124
14.3.4.1 The growing burden of chronic diseases drives the adoption of EHR solutions in Italy 124
TABLE 93 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 124
TABLE 94 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 125
TABLE 95 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 96 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 97 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 126
TABLE 98 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 126
TABLE 99 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 126
TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 127
14.3.5 SPAIN 127
14.3.5.1 Growing cases of COVID-19 have driven the demand for evidence-based solutions in Spain 127
TABLE 101 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 127
TABLE 102 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 127
TABLE 103 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 128
TABLE 104 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 105 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 128
TABLE 106 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 129
TABLE 107 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 129
14.3.6 REST OF EUROPE 130
TABLE 109 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 130
TABLE 110 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 131
TABLE 111 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131
TABLE 112 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 113 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 132
TABLE 114 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 132
TABLE 115 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 132
TABLE 116 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 133

14.4 ASIA PACIFIC 133
FIGURE 28 ASIA PACIFIC: CDSS MARKET SNAPSHOT 134
TABLE 117 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 134
TABLE 118 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 135
TABLE 119 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 135
TABLE 120 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 135
TABLE 121 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 122 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 136
TABLE 123 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 136
TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 137
TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 137
14.4.1 JAPAN 137
14.4.1.1 The rising geriatric population in Japan supports the adoption of evidence-based clinical decisions using CDSS 137
TABLE 126 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 138
TABLE 127 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 138
TABLE 128 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 138
TABLE 129 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 130 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 139
TABLE 131 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 139
TABLE 132 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140
TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 140
14.4.2 CHINA 140
14.4.2.1 China is a lucrative market for HCIT solutions due to strong government support for healthcare reforms 140
TABLE 134 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 141
TABLE 135 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 141
TABLE 136 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 142
TABLE 137 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 138 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 142
TABLE 139 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 143
TABLE 140 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143
TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 143
14.4.3 INDIA 144
14.4.3.1 The high burden of chronic diseases in India supports the market adoption of CDSS-based solutions 144
TABLE 142 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 144
TABLE 143 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 144
TABLE 144 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 145
TABLE 145 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 146 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 145
TABLE 147 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 146
TABLE 148 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 146
TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 146
14.4.4 REST OF ASIA PACIFIC (ROAPAC) 147
TABLE 150 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 147
TABLE 151 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 148
TABLE 152 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 148
TABLE 153 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 154 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 149
TABLE 155 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 149
TABLE 156 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 149
TABLE 157 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 150

14.5 REST OF THE WORLD 150
TABLE 158 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 150
TABLE 159 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 150
TABLE 160 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 151
TABLE 161 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 151
TABLE 162 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 163 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 152
TABLE 164 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 152
TABLE 165 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152
TABLE 166 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 153
14.5.1 LATIN AMERICA 153
14.5.1.1 Developments in healthcare infrastructure support the market growth in Latin America 153
TABLE 167 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 153
TABLE 168 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 154
TABLE 169 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 154
TABLE 170 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 171 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 155
TABLE 172 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 155
TABLE 173 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 156
14.5.2 MIDDLE EAST & AFRICA 156
14.5.2.1 Growing medical tourism supports the market adoption of CDSS in the Middle East & Africa 156
TABLE 175 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 157
TABLE 176 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 157
TABLE 177 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 157
TABLE 178 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 179 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 158
TABLE 180 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION) 158
TABLE 181 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 159
TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 159
15 COMPETITIVE LANDSCAPE 160
15.1 OVERVIEW 160
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 160
TABLE 183 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET 161
15.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 162
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET 162
15.4 MARKET RANKING OF PLAYERS, 2021 163
FIGURE 30 CLINICAL DECISION SUPPORT SYSTEMS MARKET RANKING, BY KEY PLAYER, 2021 163
15.5 COMPETITIVE BENCHMARKING 164
TABLE 184 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 164
TABLE 185 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS 165
TABLE 186 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS 165
15.6 COMPETITIVE LEADERSHIP MAPPING 166
15.6.1 STARS 166
15.6.2 EMERGING LEADERS 166
15.6.3 PERVASIVE PLAYERS 166
15.6.4 PARTICIPANTS 166
FIGURE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021 167
15.7 COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES 168
15.7.1 PROGRESSIVE COMPANIES 168
15.7.2 STARTING BLOCKS 168
15.7.3 RESPONSIVE COMPANIES 168
15.7.4 DYNAMIC COMPANIES 168
FIGURE 32 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET 169
15.8 COMPETITIVE SITUATIONS AND TRENDS 170
TABLE 187 PRODUCT LAUNCHES/ENHANCEMENTS 170
15.8.1 DEALS 172
TABLE 188 DEALS, JANUARY 2019–MAY 2022 172

16 COMPANY PROFILES 180
(Business overview, Products & services offered, Recent developments & MnM View)*
16.1 KEY PLAYERS 180
16.1.1 CERNER CORPORATION 180
TABLE 189 CERNER: BUSINESS OVERVIEW 180
FIGURE 33 CERNER CORPORATION: COMPANY SNAPSHOT (2019) 181
16.1.2 IBM WATSON HEALTH 184
TABLE 190 IBM: BUSINESS OVERVIEW 184
FIGURE 34 IBM: COMPANY SNAPSHOT (2021) 185
16.1.3 CHANGE HEALTHCARE 188
TABLE 191 CHANGE HEALTHCARE: BUSINESS OVERVIEW 188
FIGURE 35 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021) 188
16.1.4 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 192
TABLE 192 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: BUSINESS OVERVIEW 192
FIGURE 36 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021) 193
16.1.5 ATHENAHEALTH 197
TABLE 193 ATHENAHEALTH: BUSINESS OVERVIEW 197
16.1.6 EPIC SYSTEMS CORPORATION 200
TABLE 194 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW 200
16.1.7 ELSEVIER B.V. (A DIVISION OF RELX GROUP) 202
TABLE 195 ELSEVIER B.V.: BUSINESS OVERVIEW 202
16.1.8 ZYNX HEALTH 204
TABLE 196 ZYNX HEALTH: BUSINESS OVERVIEW 204
16.1.9 WOLTERS KLUWER N.V. 206
TABLE 197 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW 206
FIGURE 37 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2021) 207
16.1.10 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS) 209
TABLE 198 PHILIPS HEALTHCARE: BUSINESS OVERVIEW 209
FIGURE 38 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2021) 210
16.1.11 MEDITECH 213
TABLE 199 MEDITECH: BUSINESS OVERVIEW 213
*Details on Business overview, Products & services offered, Recent developments & MnM View might not be captured in case of unlisted companies.

16.2 OTHER KEY PLAYERS 215
16.2.1 NEXTGEN HEALTHCARE 215
16.2.2 SIEMENS HEALTHINEERS 216
16.2.3 EBSCO HEALTH (A DIVISION OF EBSCO INDUSTRIES, INC.) 217
16.2.4 GE HEALTHCARE 218
16.2.5 ECLINICALWORKS 218
16.2.6 RAMPMEDICAL 219
16.2.7 THE MEDICAL ALGORITHMS COMPANY 219
16.2.8 HERA-MI 220
16.2.9 CUREMD 220
16.2.10 CARECLOUD 221
16.2.11 VISUALDX 221
16.2.12 STANSON HEALTH 222
16.2.13 FIRST DATABANK 222
16.2.14 STRATA DECISION TECHNOLOGY 223
17 APPENDIX 224
17.1 DISCUSSION GUIDE 224
17.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 228
17.3 AVAILABLE CUSTOMIZATIONS 230
17.4 RELATED REPORTS 230
17.5 AUTHOR DETAILS 231

ページTOPに戻る

Table of Contents

Summary

The global clinical decision support systems (CDSS) market is projected to reach USD 2.2 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market is driven by the various government regulations and initiatives that are implemented to promote the adoption of HCIT solutions, increase in the adoption of CDSS integrated EHRs, growth in collaborations and partnerships between competitor companies, rgrowing incidence in medication errors, and the development of mHealth and big data tools.
However, high investments for the implementation of CDSS and interoperability issues coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.

“Software segment is expected to grow at the highest rate during the forecast period”
On basis of component the CDSS market is segmented into : services, software, and hardware. In 2021, the services segment accounted for the largest share of this market. Growth in this segment is attributed to the recurring nature of the services such as training and development, installation, consulting, and maintenance.

“The On-premise solutions segment is estimated to account for the largest share of the Clinical decision support systems market in 2022”
On basis of delivery mode , Clinical decision support systems are delivered to end users through on-premise and cloud-based modes. The on-premise mode of delivery accounted for the largest share of the clinical decision support systems market in 2021. The cloud-based mode of delivery, on the other hand, is estimated to grow at the highest CAGR due to lower capital expenses and operational costs incurred in this model, alongside its scalability, flexibility, and affordability.

“Conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market”
Based on application, the CDSS market is segmented into conventional CDSS and advanced CDSS. In 2021, the conventional CDSS segment accounted for the largest share of the market. Conventional CDSS has largest share in the market primarily due to the increasing adoption of CDSS by healthcare organizations to provide guidance & reminders to caregivers at the point-of-care.

“Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market”
Based on product, the CDSS market is segmented into integrated CDSS and standalone CDSS. In 2021, the integrated CDSS segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing adoption of integrated CDSS in healthcare settings and organizations.

“The therapeutic CDSS segment is expected to grow with the highest CAGR during the forecast period”
Based on type, the clinical decision support systems market is segmented into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2021. This segment is estimated to grow at a higher CAGR during the forecast period. This segment's large share and high growth rate can be attributed to factors such as therapeutic CDSS being preferred by clinicians over diagnostic CDSS as it is better compatible with clinical workflows. It is also convenient to use, as it doesn’t restrict the healthcare provider’s autonomy.

“Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market”
Based on the model, the CDSS market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2021, the knowledge-based CDSS segment accounted for the largest share of the market. This segment is also estimated to register the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the several benefits of these systems, such as helping clinicians with knowledge-based reasoning and to make clinical decisions in uncertainties. These systems can also be integrated into clinical workflows and are less prone to errors.

“The Active CDSS segment is expected to grow with the highest CAGR during the forecast period”
Based on the interactivity level, the CDSS market can be segmented into active CDSS and passive CDSS. The active CDSS segment accounted for the largest share of the market in 2021 and is projected to grow at the highest CAGR during the forecast period.

“Inpatient settings accounted for the largest share of the global Clinical decision support systems market”
Based on setting, the CDSS market is segmented into inpatient and ambulatory care settings. Inpatient settings accounted for the largest share of the CDSS market in 2021. Inpatient settings have to capture and analyze large volumes of patient data, this results in the increasing adoption of integrated healthcare IT modules.

“North America to dominate the Clinical decision support systems market in 2022”
North America accounted for the largest share of the global clinical decision support systems market in 2021. The large share of the North American market can be attributed to the noticeable investments in HCIT solutions, regulatory mandates that favor the implementation of CDSS, the presence of key market players in the region, and the rise in medication errors in the US and Canada.
The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the factors such as the presence of a large geriatric population, improved government regulations, the high burden of chronic diseases, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the CDSS market in Asia.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
• By Designation: C-level (26%), Director-level (17%), and Others (57%)
• By Region: North America (40%), Europe (20%), Asia Pacific (30%), and RoW (10%)

Prominent players operating in the CDSS market are Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Healthcare (Netherlands), Wolters Kluwer N.V. (Netherlands), Zynx Health (US), Elsevier B.V. (UK), IBM Watson Health (US), Allscripts Healthcare LLC (US), athenahealth (US), NextGen Healthcare (US), Siemens Healthineers (US), EBSCO Health (US), GE Healthcare (US), eClinicalWorks (US), RAMPMedical (Germany), The Medical Algorithms Company Limited (UK), Hera-MI (France), CureMD Healthcare (US), CareCloud, Inc (US), Visual DX (US), Stanson Health (US), First Databank, Inc (US), and Strata Decision Technology (US).

Research Coverage
• The report studies the Clinical decision support systems market based on component, delivery mode, product, model, interactivity level, application, setting, type, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Clinical decision support systems market
• The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Clinical decision support systems market and provides them information on key market drivers, restraints, challenges, and opportunities.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（cloud）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（cloud）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?